No Data
No Data
We're Not Worried About Anavex Life Sciences' (NASDAQ:AVXL) Cash Burn
Anavex Life Sciences Faces Manufacturing Challenges Impacting Product Launch and Financial Stability
Greenfire Resources, Hut 8, TeraWulf, MicroStrategy And Other Big Stocks Moving Higher On Tuesday
Anavex (AVXL.US) is bullish: the new drug application for Alzheimer's disease has been accepted by the EU.
According to Zhito Finance APP, Biotechnology company Anavex Life Sciences (AVXL.US) saw its stock price rise by 30% on Monday, after the company released its third-quarter Earnings Reports and announced that EU regulators have accepted its marketing application for the Alzheimer's candidate drug blarcamesine.
Anavex Life Sciences | 10-K: FY2024 Annual Report
Anavex Stock Rallies 30% on Business Updates